Adcock Ingram Holdings Limited, a prominent player in the South African pharmaceutical industry, is headquartered in Johannesburg, South Africa (ZA). Founded in 1890, the company has established itself as a leader in the manufacture and distribution of a diverse range of healthcare products, including prescription medications, over-the-counter drugs, and consumer health products. With a strong presence across Southern Africa, Adcock Ingram is renowned for its commitment to quality and innovation, offering unique formulations that cater to various health needs. The company has achieved significant milestones, including strategic partnerships and expansions that enhance its market position. Adcock Ingram's dedication to improving health outcomes has solidified its reputation as a trusted name in the pharmaceutical sector, making it a key contributor to the region's healthcare landscape.
How does Adcock Ingram Holdings Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Adcock Ingram Holdings Limited's score of 32 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Adcock Ingram Holdings Limited reported total carbon emissions of approximately 131.5 million kg CO2e. This figure includes Scope 1 emissions of about 17.2 million kg CO2e, Scope 2 emissions of approximately 52.6 million kg CO2e, and Scope 3 emissions totalling around 63.5 million kg CO2e. The company has shown a slight decrease in total emissions from 2023, where emissions were reported at approximately 134 million kg CO2e. The breakdown of emissions for 2023 indicates Scope 1 emissions of about 21.2 million kg CO2e and Scope 3 emissions of approximately 60.3 million kg CO2e. Notably, the Scope 1 and 2 combined emissions for 2023 were around 73.7 million kg CO2e. Adcock Ingram has not set specific reduction targets or initiatives as part of its climate commitments, and there are no reported SBTi (Science Based Targets initiative) reduction targets. The company is currently focused on monitoring and reporting its emissions without formalised reduction strategies. Overall, Adcock Ingram Holdings Limited is actively disclosing its carbon emissions data, but it lacks defined reduction commitments or initiatives at this time.
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | 2024 | |
|---|---|---|
| Scope 1 | 21,221,000 | 00,000,000 |
| Scope 2 | - | 00,000,000 |
| Scope 3 | 60,330,000 | 00,000,000 |
Adcock Ingram Holdings Limited's Scope 3 emissions, which increased by 5% last year and increased by approximately 5% since 2023, demonstrating supply chain emissions tracking. A significant portion of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 48% of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 33% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Adcock Ingram Holdings Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

